Genmab A/S (GMABN) Income Statement
0 Followers
Genmab A/S Income Statement
Last quarter (Q2 2026), Genmab A/S's total revenue was kr1.16B, an increase of 24.89% from the same quarter last year. In Q2, Genmab A/S's net income was kr303.00M. See Genmab A/S’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 3.86B | kr 21.53B | kr 16.47B | kr 14.51B | kr 8.48B | |
| kr 3.54B | kr 20.54B | kr 16.25B | kr 14.51B | kr 8.48B | |
| kr 2.24B | kr 13.84B | kr 10.93B | kr 8.24B | kr 5.46B | |
| Depreciation and Amortization | kr 71.00M | kr 413.00M | kr 327.00M | kr 362.00M | kr 250.00M |
| kr 1.37B | kr 9.70B | kr 5.99B | kr 7.33B | kr 3.27B | |
| kr 1.30B | kr 7.00B | kr 5.32B | kr 6.30B | kr 2.95B | |
| kr -47.73M | kr 2.16B | kr 316.00M | kr 640.00M | kr 965.00M | |
| kr 1.25B | kr 9.16B | kr 5.64B | kr 6.95B | kr 3.98B | |
| kr 999.19M | kr 7.84B | kr 4.35B | kr 5.45B | kr 2.96B | |
| Per Share Metrics | |||||
| Basic EPS | kr 16.08 | kr 122.21 | kr 66.64 | kr 83.38 | kr 46.00 |
| Diluted EPS | kr 15.94 | kr 121.36 | kr 66.02 | kr 82.59 | kr 45.54 |
| Weighted Average Shares Outstanding | 62.15M | 64.63M | 65.31M | 65.39M | 65.40M |
| Weighted Average Shares Outstanding (Diluted) | 62.69M | 64.63M | 65.92M | 66.01M | 66.05M |
Currency in DKK
